Markets › India › NSE › LINCOLN

Lincoln Pharmaceuticals Ltd

NSE:LINCOLNHealthcare

₹535.35−1.88%At closeAt close · Mon 19 Oct · ≈ AED 20.68 · Market cap $115.16M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	51.4%	52.6%	51.3%	51.2%	53.3%	32.8%	—	—
Operating margin	17.4%	35.2%	15.4%	14.3%	14.2%	12.4%	12.4%	+0.0 pts
Net margin	15.0%	14.8%	14.4%	16.1%	13.2%	13.1%	13.1%	+0.0 pts
EBITDA margin	22.4%	22.5%	22.1%	23.1%	19.9%	19.5%	—	—
Return on equity	17.0%	16.0%	14.5%	15.7%	12.3%	11.6%	11.6%	+0.0 pts
Return on assets	13.8%	13.0%	12.4%	13.3%	10.3%	9.9%	9.9%	+0.0 pts
Return on capital employed	19.1%	37.2%	15.1%	13.7%	12.8%	10.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.1%	0.4%	0.3%	0.2%	0.0%	0.5%	—	—
Interest coverage	46.1×	113.7×	38.4×	56.8×	47.1×	82.1×	—	—
Current ratio	4.1×	3.9×	5.1×	4.8×	4.7×	5.3×	5.3×	+0.0%
Quick ratio	3.5×	3.1×	4.1×	4.0×	4.0×	4.5×	—	—
Cash ratio	0.2×	0.1×	0.1×	0.1×	0.1×	0.3×	0.3×	+0.0%
Asset turnover	0.9×	0.9×	0.9×	0.8×	0.8×	0.8×	—	—
Inventory turnover	4.3×	3.1×	3.5×	3.7×	3.7×	5.6×	—	—
Receivables turnover	2.8×	3.1×	3.1×	2.8×	3.1×	2.8×	—	—
Dividend payout	0.0%	4.3%	4.1%	3.2%	4.4%	4.1%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.